Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen (Q80177579)
Jump to navigation
Jump to search
scientific article published on 01 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen |
scientific article published on 01 January 2006 |
Statements
Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen (English)
Hideaki Kishimoto
Masao Fukunaga
Kazuhiro Kushida
Masataka Shiraki
Akira Itabashi
Hajime Nawata
Toshitaka Nakamura
Hiroaki Ohta
Kunio Takaoka
Yasuo Ohashi
Risedronate Phase III Research Group
1 January 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference